Heart Attacks are Preventable!

EP51: Aspirin: Good or Bad?

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary EP51: Aspirin: Good or Bad? Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health. In this episode, he addresses recent media headlines questioning aspirin's benefits by examining three major clinical trials—ASPRI, ARRIVE, and ASCEND—that collectively studied over 45,000 patients to clarify when aspirin is actually beneficial and when it isn't necessary. Key Takeaways: Recent headlines warning against aspirin are based on large, robust trials (ASPRI, ARRIVE, ASCEND) showing that healthy individuals and average-risk patients don't need aspirin for disease prevention. The ASPRI trial of 20,000 people over age 70 found that regular aspirin didn't improve quality of life, cardiovascular outcomes, or reduce dementia in healthy elderly individuals. The ARRIVE trial showed aspirin reduced heart attack risk in intermediate-risk patients but offered no significant benefit for stroke and came with increased bleeding risk. The ASCEND trial of over 15,000 asymptomatic diabetics over seven years showed aspirin was not compelling for primary prevention in this population. Aspirin remains strongly beneficial in secondary prevention—for patients who have already experienced a heart attack, stroke, stent placement, bypass surgery, or peripheral vascular disease. Dr. Bishop prescribes aspirin in primary prevention only for high-risk patients he has imaged and confirmed have significant plaque buildup in their coronary arteries. The key message is that aspirin decisions should never be based on headlines alone but require individualized conversations between patients and their doctors about specific risk-benefit ratios. Patients currently taking aspirin prescribed by their doctor should not stop without consulting their physician, as the recent trials don't apply to those with existing cardiovascular disease or high-risk imaging findings. Read more

EP50: 50th Podcast

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary: EP50: 50th Podcast Introduction: Dr. Warwick Bishop is a practicing cardiologist and author dedicated to improving patient care through heart health education. In this milestone 50th episode, he celebrates nearly a year of weekly podcasting and reflects on his growing community engagement, including his new role as AMCAL's Heart Health Ambassador and plans to launch an internet-based membership site called the Healthy Heart Network. Key Takeaways: Dr. Bishop has successfully released 50 weekly podcasts over nearly a year, establishing himself as a consistent educator in cardiac health The podcast has reached hundreds of downloads with an engaged community including nearly 1,000 members in the Know Your Real Risk of Heart Attack Facebook group Dr. Bishop has grown his professional network to nearly 4,000 LinkedIn connections and regularly sells e-books internationally, indicating global interest in his content He was appointed as AMCAL's Heart Health Ambassador, expanding his platform and credibility in cardiac health education Dr. Bishop spent time in the United States recording a 13-episode TV series called "The Healthy Heart Network TV Show" to expand his educational reach The upcoming Healthy Heart Network membership site will provide comprehensive, up-to-date information and resources for people seeking quality heart health guidance Dr. Bishop emphasizes that educated patients consistently receive better healthcare outcomes, making patient education his core mission He encourages listener feedback and welcomes questions about topics for future podcast episodes to ensure content relevance Read more

EP49: Takotsubo or Broken Heart Syndrome

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Introduction Dr. Warwick Bishop is a practicing cardiologist and author dedicated to patient education in heart health, hosting this episode to discuss Takotsubo Syndrome, commonly known as Broken Heart Syndrome. The episode explores how severe emotional stress can trigger a heart condition that mimics a heart attack but is caused by nervous system and hormonal responses rather than blocked arteries. This educational discussion aims to help patients understand this rare but important cardiac condition. Key Takeaways: Takotsubo Syndrome (Broken Heart Syndrome) is triggered by significant emotional stress in approximately 70% of cases, such as fights, distressing life events, surgical anxiety, or intense emotional situations like soccer games. The condition predominantly affects middle-aged women, though it can occur in men at much lower frequency. Takotsubo presents identically to a heart attack with chest pain, ECG changes, and elevated troponin levels in blood tests, making it difficult to distinguish without further investigation. The characteristic feature is "apical ballooning," where the heart base functions normally but the apex (tip) balloons outward, resembling an octopus pot—the Japanese origin of its name. Takotsubo is caused by excessive nervous system activity and stress hormones from the adrenal glands affecting heart muscle function, not by blocked coronary arteries. The diagnosis is made by exclusion—patients must show all features of a heart attack while having clear, unblocked coronary arteries. The condition is relatively rare, occurring in approximately 5-10% of people presenting with apparent heart attack symptoms, and is rarely fatal. Most patients recover fully within several months, and recurrent episodes occur in only about 10% of cases. Treatment involves medications for heart failure and beta-blockers to reduce nervous system activity and hormonal impact on the heart. Follow-up care includes coronary angiography or CT imaging to rule out blocked arteries, plus an ultrasound and ECG at three months to confirm full heart recovery. Read more

EP48: Can We Reverse Coronary Artery Disease?

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Introduction: Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health. In this episode, he discusses whether coronary artery disease can be reversed, sharing two compelling patient cases that demonstrate the real-world effectiveness of aggressive cholesterol management and lifestyle modifications in reducing arterial plaque. Key Takeaways: Coronary artery disease plaque can actually regress and be reversed through aggressive cholesterol management, statins, and other pharmaceutical interventions combined with lifestyle changes. Peter's case demonstrates significant plaque regression in his left main artery over several years of compliant cholesterol-lowering therapy, to the point where his native artery may now be supplying more blood flow than his bypass graft. Aggressive intervention and monitoring for cardiovascular risk is beneficial even before symptoms appear, as demonstrated by Phil's preventive care approach when soft plaque was detected during routine screening. Soft (non-calcific) plaque is the most dangerous type because it can rupture, making its reduction through treatment a major health victory. Calcified plaque, while indicating disease presence, is actually a marker of stability and represents a positive transformation when soft plaque converts to calcium through treatment. Educated, compliant patients who maintain target cholesterol levels consistently see better outcomes and can actually reverse the arterial disease process. Cholesterol-lowering medications like statins and ezetimibe, when combined with proper diet, exercise, and triglyceride management, have proven effectiveness in clinical practice beyond just theoretical studies. Regular follow-up imaging (CT scans, angiograms) allows doctors to monitor plaque progression and adjust treatment targets as guidelines evolve and improve. Read more

EP47: Beating The Same Old Drums

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode 47: Beating The Same Old Drums - Summary Dr. Warwick Bishop is a practicing cardiologist and author dedicated to improving patient care through heart health education. In this episode, he passionately addresses two recurring frustrations from his clinical practice: patients who don't know their medications and those who unilaterally stop taking prescribed drugs without consulting their doctor. Through real patient examples, Dr. Bishop emphasizes the critical importance of medication awareness and informed decision-making in cardiac care. Key Takeaways: Patients should maintain an up-to-date written list of all medications and keep it in their wallet for emergencies and medical consultations. Not knowing what medications you're taking prevents doctors from accurately diagnosing medication side effects and making informed treatment decisions. Pharmacy staff can be valuable resources for obtaining clear, accurate medication lists that patients can carry with them. Medication lists can be lifesaving in emergency situations when patients are unable to communicate their medical history themselves. Preventative medications like statins don't produce noticeable daily effects, making patients question their necessity—but they work to extend lifespan over time. Patients should never unilaterally stop medications based on social media, anecdotal neighbor experiences, or general information that doesn't account for their specific clinical situation. Open dialogue between patients and doctors about medication concerns is essential before making any changes to prescribed treatments. Doctors prescribe medications based on careful risk-benefit analysis tailored to individual patient circumstances, not arbitrary decisions. Patient education about the difference between symptom-relieving drugs and preventative drugs can improve medication compliance and long-term health outcomes. Medical decisions should be collaborative, informed discussions between healthcare providers and patients rather than unilateral patient choices. Read more

EP46: Responding To A Facebook Group Question About Calcification

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Podcast Summary Dr. Warrick Bishop is a practicing cardiologist and author dedicated to patient education in heart health, hosting this podcast to help people understand cardiovascular concepts. In this episode, he addresses multiple questions from his Facebook community about vascular and cardiac terminology, breaking down complex medical concepts related to arterial disease, calcification, and treatment options. Key Takeaways: Calcification is a marker of plaque buildup in arteries, where calcium binds to cholesterol deposits and can be used to detect atherosclerosis in the heart and other arteries Claudication refers to burning or cramping pain in the legs during exercise, caused by narrowed arteries restricting blood flow—essentially "angina of the legs" A bypass is a surgical procedure using another vessel (conduit) to route blood around a blocked or diseased artery segment, from a healthy area before the blockage to a healthy area after it Bypass grafts in the heart typically use veins from the legs, arteries from the arm, or arteries from inside the chest wall, while leg bypasses may use synthetic Dacron material Angioplasty is a procedure that opens narrowed arteries by inflating a balloon, which deploys a stent that acts as a scaffold to keep the artery open Modern angioplasty differs from older techniques by combining balloon inflation with stent deployment in a single procedure rather than using balloons in isolation A calcified aorta indicates plaque buildup within the aortic wall and suggests potential disease, loss of elastic tissue, and possible enlargement of the aorta Read more

EP45: Weight And Fidgeting

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. EP45: Weight And Fidgeting - Summary Dr. Warwick Bishop is a practicing cardiologist and author dedicated to patient education about heart health. In this episode, he discusses key insights from the Australian Atherosclerosis Society meeting, focusing on the relationship between weight management, blood pressure, and exercise on cardiovascular health. The episode emphasizes practical lifestyle changes that can significantly reduce cardiovascular risk. Key Takeaways: One kilogram of weight loss results in approximately one millimeter of mercury reduction in blood pressure, making weight management a direct lever for blood pressure control. Losing 5 to 10 kilograms of weight provides health benefits comparable to taking blood pressure medication. A 10-kilogram weight loss for overweight or obese individuals produces a 20-25% relative risk reduction in cardiovascular events. Prolonged periods of sitting are closely linked with worse health outcomes and metabolic dysfunction, regardless of exercise habits. Breaking up sedentary time by moving around every 15-30 minutes makes a significant difference in cardiovascular health and metabolism. Fidgeting and small movements like bouncing your legs while sitting can provide metabolic benefits by burning energy and altering metabolism. Weight management should be an ongoing priority—preventing weight gain is easier than losing weight after it accumulates. Different fitness levels require different exercise approaches, but movement is beneficial for people at all weights and fitness levels. Read more

EP44: Clots And Drugs

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Summary: EP44 - Clots And Drugs Dr. Warwick Bishop is a practicing cardiologist and author dedicated to educating patients about heart health. In this episode, he responds to a Facebook question about blood-thinning medications, specifically warfarin and Prasugrel, by explaining how different drug classes work to prevent clot formation in the body. The episode provides a foundational understanding of antiplatelet agents versus anticoagulants and when each type is used. Key Takeaways: Clot formation in the body is driven by two main mechanisms: platelets (small sticky blood components) and the coagulation cascade (proteins that form clots) Antiplatelet drugs like aspirin, clopidogrel, ticagrelor, and Prasugrel prevent platelets from clumping together and are primarily used in the arterial system, such as in stents and for coronary artery disease Anticoagulant drugs work by thinning the blood through the coagulation cascade and are used to affect the proteins involved in clot formation Warfarin is the historically most widely used anticoagulant, but newer alternatives called NOACs (non-vitamin K dependent oral anticoagulants) have entered the market with different mechanisms of action The three main NOAC medications currently available are rivaroxaban (Xarelto), dabigatran (Pradaxa), and apixaban (Eliquis) NOACs target specific parts of the coagulation cascade differently than warfarin, offering patients alternative blood-thinning options Understanding which drug class addresses platelets versus proteins in clot formation helps patients and doctors select appropriate treatments for their specific conditions Read more

EP43: Small Dense And Light Fluffy Particles

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Summary Dr. Warwick Bishop, a practicing cardiologist and author focused on heart health education, discusses findings from the European Atherosclerosis Society conference in Brisbane regarding LDL cholesterol particle size and density. The episode challenges the popular assumption that large fluffy LDL particles are dramatically safer than small dense particles simply based on their size difference. Key Takeaways: Endothelial pores in arteries are approximately 70 microns in diameter, while large fluffy LDL particles are about 50 microns and small dense particles are about 40 microns—a relatively modest difference of only 10 microns. The critical distinction between particle types lies in their density, not just diameter, with density differences related to the radius cubed (radius³), which creates a much more significant difference than the small diameter variance. The actual size difference between large fluffy and small dense particles (10 microns) may not be the major determining factor in whether particles penetrate artery walls, suggesting the conventional narrative oversimplifies the issue. Favoring large fluffy particles remains beneficial because they correlate with a healthier metabolic environment: lower insulin levels, lower triglycerides, and higher HDL cholesterol. Maintaining triglyceride levels below 1.1-1.3 millimoles per liter effectively shifts the LDL particle profile from small dense to large fluffy particles. Reducing carbohydrate intake is key, as carbohydrates drive insulin production, which directly promotes small dense LDL formation while simultaneously lowering HDL and raising triglycerides. While large fluffy particles remain preferable to small dense particles, particle size alone is likely not the primary driver of coronary event risk. Read more

EP42: Trip To America

EP42: Trip To America Read more